Please note that this webinar was recorded in 2016. All AMPEDTM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.
AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.
This collection will give you access to the recordings of the presentations (listed below). CME/CMLE or SAM is not available for this collection
Speakers will highlight the differences and challenges of European molecular diagnostic approaches compared to those in the U.S. with respect to Clostridium difficile-associated disease and for high-risk HPV detection in cervical cancer screening.
Learning Objectives:
- Outline differences between European diagnostic models compared to the US.
- Describe available tests that have been incorporated into European testing paradigms.
- Identify differences in patient outcomes observed using these different diagnostic practices
Testing Models for Clostridium difficile Infection Used in the UK
Mark Wilcox, MD, FRCPath, Leeds Teaching Hospital & University of Leeds, Leeds, West Yorkshire, UK
HPV Primary Screening: Challenges of Application and Implementation - and Priorities for Research
Kate Cuschieri, BSc, PhD, NHS Lothian, Edinburgh, United Kingdom
Duration: 1.5 hr
Recording Date: November 10, 2016
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
